- Home
- ACIU vs OPRT Comparison
ACIU vs OPRT Comparison
Compare ACIU & OPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACIU | OPRT |
|---|---|---|
| Founded | 2003 | 2005 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.3M | 199.4M |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ACIU | OPRT |
|---|---|---|
| Price | $2.85 | $5.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $10.00 | $7.00 |
| AVG Volume (30 Days) | 252.0K | ★ 378.0K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 127.18 |
| EPS | N/A | ★ 0.53 |
| Revenue | N/A | ★ $956,685,000.00 |
| Revenue This Year | $706.75 | $32.79 |
| Revenue Next Year | $321.13 | $4.47 |
| P/E Ratio | ★ N/A | $10.81 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.55 | $4.03 |
| 52 Week High | $4.00 | $7.73 |
Technical Indicators
Market Signals| Indicator | ACIU | OPRT |
|---|---|---|
| Relative Strength Index (RSI) | 45.07 | 68.05 |
| Support Level | $2.56 | $5.04 |
| Resistance Level | $2.99 | $6.22 |
| Average True Range (ATR) | 0.21 | 0.24 |
| MACD | -0.02 | 0.09 |
| Stochastic Oscillator | 13.19 | 74.25 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About OPRT Oportun Financial Corporation
Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.